Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT03945162

Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Pa…

This is a phase II, open-label, single-arm, multi-center Study conducted in Canada and the United States. Patients with Non-Muscle Invasive Bladder Cancer ("NMI…

United States90 participantsStarted 2019-08-30

Treatment: Ruvidar® (TLD-1433) bladder infusion and PDT

Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Pa…

All recent trials (1 shown)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Pa…

All recent trials (1 shown)